Renaissance Technologies
ONCO icon

Renaissance Technologies’s Onconetix ONCO Stock Holding History

Renaissance Technologies’s Portfolio ONCO Stock Details ONCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Hold
0
– -$11K – 3966
2023
Q4 		– Hold
0
– – – 3634
2023
Q1 		– Hold
0
– -$25K – 4281
2022
Q4 		– Sell
-1
Closed -$214K – 3925
2022
Q3 		$150K Buy
+1
New +$438K ﹤0.01% 3477
2022
Q2 		– Hold
0
– – – 3895

Other funds holding ONCO

AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies's ONCO Position: Q1 2024 in Review

Renaissance Technologies held its Onconetix (ONCO) position steady in Q1 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3966.

Renaissance Technologies first reported a position in ONCO in Q3 2022 and has held it in 1 quarter since. The position peaked at $150K in Q3 2022. 6 funds tracked by Wall St. Rank hold ONCO as of Q1 2024.

  • Renaissance Technologies held 0 shares of Onconetix worth $0 as of Q1 2024.
  • Renaissance Technologies left its Onconetix share count unchanged in Q1 2024.
  • Onconetix made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2024, its #3966 holding.
  • Renaissance Technologies first reported a position in Onconetix in Q3 2022 and has held it in 1 quarter since.
  • Renaissance Technologies's Onconetix position peaked at $150K in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Onconetix as of Q1 2024.

Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.